Medicine and Dentistry
Absorbed Dose
86%
Americium 241
8%
B-Cell Lymphoma
12%
Blood
24%
Bone Marrow
16%
Breast Cancer
9%
Carcinoembryonic Antigen
6%
Cells
21%
Clinical Dosimetry
10%
Combination Therapy
17%
Development
12%
Dosimetry
100%
Drug Megadose
11%
Ex Vivo
8%
Extracorporeal
44%
Human
10%
Immunoabsorption
33%
Injection
24%
Iodine 124
7%
Iodine 125
26%
Iodine 131
24%
Irradiation
19%
Liver
15%
Measurement
12%
Metabolic Rate
6%
Monte Carlo Method
14%
Nanoparticle
10%
Nanoparticle
7%
Neuroendocrine Tumor
6%
Nuclear Medicine
13%
Organ
29%
Particle Therapy
16%
Patient
38%
Platelet
11%
Positron Emission Tomography
12%
Positron Emission Tomography - Magnetic Resonance Imaging
7%
Prostate Cancer
44%
Quantitative Imaging
7%
Radioimmunotherapy
52%
Radioisotope
51%
Radionuclide Therapy
35%
Radiosensitivity
7%
Single-Photon Emission Computed Tomography
34%
Technetium-99
28%
Testes
19%
Therapeutic Procedure
55%
Therapeutics
13%
Treatment Planning
6%
Tumor Cell
6%
Xenograft
16%
Pharmacology, Toxicology and Pharmaceutical Science
Actinium 225
5%
Alpha 1 Microglobulin
5%
Antibodies
28%
Antioxidant
9%
Autoradiography
18%
B Cell Lymphoma
17%
Bear
5%
Biodistribution
21%
Blood Toxicity
7%
Castration Resistant Prostate Cancer
9%
Cell Death
5%
Chemotherapy
6%
Colon Carcinoma
13%
Dosimetry
59%
Endotoxin
10%
Gamma Ray
11%
Glucose
5%
Ibritumomab Tiuxetan
5%
Indium 111
46%
Inhalation
5%
Iodine-131
17%
Irradiation
7%
Kidney Injury
7%
Lutetium 177
59%
Malignant Neoplasm
17%
Maximum Tolerated Dose
5%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
5%
Monoclonal Antibody
5%
Mouse Model
11%
Nanoparticle
7%
Neoplasm
84%
Nephrotoxicity
17%
Peptide
23%
Pharmacokinetics
20%
Polyethylene Terephthalate
5%
Primate
7%
Prostate Cancer
10%
Prostate Specific Antigen
5%
Radioisotope
68%
Radioligand
8%
Radiopharmaceutical Agent
22%
Rat Model
10%
Receptor
21%
Recombinant
9%
Sulfur 35
5%
Superparamagnetic Iron Oxide Nanoparticle
7%
Synapsin I
5%
Technetium 99m
25%
Toxicity
14%
Yttrium 90
21%